Clinical Trials on Mycose fongique transformée

Total 7744 results

Universitaire Ziekenhuizen KU Leuven

Completed

Immunological Interaction Between the Host and Candida Albicans Biofilm

Candidiasis

Belgium
Astellas Pharma Global Development, Inc.

Terminated

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis (MAGIC-2)

Candidiasis

Philippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
National Institute of Allergy and Infectious Diseases...

Completed

Funguria in Hospitalized Patients

Candidiasis

United States
Merck Sharp & Dohme LLC

Completed

Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

Candidiasis
Institut National de la Santé Et de la Recherche...

Unknown

Fluconazole Versus Micafungin in Neonates With Candidiasis (TINN)

Candidiasis

Belgium, France, Italy, Netherlands, Spain
Pfizer
Vicuron Pharmaceuticals

Completed

The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

Candidiasis

United States
Alessandro Pasqualotto
Hospital de Clinicas de Porto Alegre; Irmandade Santa Casa de Misericórdia... and other collaborators

Completed

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

AIDS | Histoplasmosis

Brazil
Astellas Pharma Inc

Completed

A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant

Fungal Infections

United States
Merck Sharp & Dohme LLC
JSS Medical Research Inc.

Completed

A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) (TIP)

Mycoses
Gilead Sciences

Completed

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Fungus Diseases

Italy
Scynexis, Inc.

Completed

ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects

Fungal Disease

United Kingdom
Janssen Research & Development, LLC

Terminated

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Mycoses

India
Bayside Health
Monash University; Western Sydney Local Health District; Eastern Health; Fremantle... and other collaborators

Unknown

fungalAi for Fungal Surveillance & Antifungal Stewardship (fungalAi)

Fungal Infections

Australia
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Different Formulation of Voriconazole

Fungus Infection
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)

Fungal Infections
National Institute of Allergy and Infectious Diseases...
Pfizer

Completed

Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)

HIV Infections | Mycoses | Candidiasis

United States, Tanzania
UNC Lineberger Comprehensive Cancer Center
Stand Up To Cancer; University Cancer Research Fund at Lineberger Comprehensive...

Recruiting

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Neoplasms | Immune System Diseases | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Mycosis Fungoides | Sezary Syndrome | Cutaneous T Cell Lymphoma | Gray Zone Lymphoma | Cutaneous Lymphoma | Lymphomatoid Papulosis | Cutaneous Anaplastic Large Cell Lymphoma

United States
Acrotech Biopharma Inc.

Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma

United States, Italy
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Aspergillus PCR Early Detection in High Risk Oncohematological Patients (PCRAGA)

Infections

Spain
Thinq Pharma-CRO Pte. Ltd.
Unique Pharmaceuticals Ltd, India; THINQ Pharma CRO Ltd.

Unknown

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis. (TPC)

Oropharyngeal Candidiasis

India
Merck Sharp & Dohme LLC

Completed

An Observational Study of Fungal Biomarkers (MK-0000-089)

Aspergillosis
Zhixin Liang
Wenzhou Medical University; The First Affiliated Hospital of Nanchang University and other collaborators

Unknown

Clinical Trial of Pulmonary Cryptococcosis in China (MCTOPCIC)

Cryptococcosis
Astellas Pharma Inc

Terminated

Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

Aspergillosis

United States
University Hospital Inselspital, Berne

Completed

Surveillance of Fungal Infections During Construction Activity

Aspergillosis

Switzerland
Capital Medical University

Unknown

Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week

Pulmonary Candidiasis

China
National Cancer Institute (NCI)

Completed

Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units

Candidiasis

United States
Janssen Pharmaceutica

Completed

An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis

Vulva; Candidiasis
University of Arkansas

Withdrawn

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

Aspergillosis

United States
Pfizer

Terminated

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Aspergillosis

United States
Assiut University

Completed

THYME AND CARVACROLL Nanoparticle Effect on Fungi

Aspergillosis

Egypt
Astellas Pharma Inc

Completed

Study of FK463 for the Treatment of Invasive Aspergillosis

Aspergillosis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Pfizer

Terminated

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

Candidiasis

Hong Kong, Hungary, China, Czech Republic, Mexico, Philippines, Poland, Slovakia
Merck Sharp & Dohme LLC

Completed

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Aspergillosis
National Institute of Allergy and Infectious Diseases...

Terminated

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Candidiasis

United States
Pfizer

Completed

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Aspergillosis

United States, Australia, Canada, Greece, Belgium, Germany, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, Thailand, Brazil, Czech Republic, France, India, Italy, Netherlands, Peru, Portugal, Singapore, Switzerland, ... and more
Pfizer
Vicuron Pharmaceuticals

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Aspergillosis

United States
Basilea Pharmaceutica

Completed

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Fungal Infection

Netherlands
University of Maryland, Baltimore

Completed

Itraconazole Oral Absorption

Fungal Infection

United States
Pfizer

Completed

Vfend Special Investigation For Prophylaxis

Fungal Infection
University Hospital, Grenoble

Completed

Mucormycosis in ICU (ZygoRéa)

Mucormycosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)

Zygomycosis

France
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Candidiasis

Germany
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Fungal Infection

United States
Children's Hospital of Philadelphia
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Fluconazole Pharmacokinetics in Infants

Fungal Infection

United States
Pfizer
Mclean Hospital

Completed

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

Fungal Infection
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory...

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Refractory Primary Mediastinal (Thymic)... and other conditions

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Fungal Infection

China
Basilea Pharmaceutica

Completed

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

Fungal Infection

Netherlands
Basilea Pharmaceutica

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection

Netherlands

Clinical Trials on Mycose fongique transformée

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations